Skip to content

Flexion Therapeutics Inc

Delisted

CIK 1419600fmd_0YC1W7K4XW30D5PB7Z79GE7WBJManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2021, 37 periods

Latest annual · FY2020

Millions
Total revenues
86
Gross profit
66
Operating income
(93)
Net income
(114)
Free cash flow
(81)

Latest quarter · Q3 FY2021

Millions
Total revenues
21
Gross profit
18
Operating income
(24)
Net income
(30)
Free cash flow
(15)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2017 to FY2020
+522.3%
Revenue, 5 yearsFY2015 to FY2020
n/m
Net income, 5 yearsFY2015 to FY2020
n/m

Flexion Therapeutics Inc financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2020FY2019ChangeSource
Revenue$85.6 million$73 million+17.3%10-K 2021-03-10 · proof
Gross profit$66.3 million$63 million+5.2%10-K 2021-03-10 · proof
Operating income-$93 million-$136.3 million10-K 2021-03-10 · proof
Net income-$113.7 million-$149.8 million10-K 2021-03-10 · proof
Cash from operating activities-$70.6 million-$148.8 million10-K 2021-03-10 · proof
Free cash flow-$80.6 million-$152.7 million10-K 2021-03-10 · proof
Total assets$251.9 million$217.6 million+15.8%10-K 2021-03-10 · proof
Total liabilities$268.6 million$237.7 million+13%10-K 2021-03-10 · proof
Cash and cash equivalents$107.7 million$82.3 million+30.9%10-K 2021-03-10 · proof
Total debt$60.9 million$40.2 million+51.6%10-K 2021-03-10 · proof
What was Flexion Therapeutics Inc's revenue in fiscal 2020?
Flexion Therapeutics Inc reported revenue of $85.6 million for fiscal 2020 (the year ended Dec 31, 2020), against $73 million the year before (+17.3%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What was Flexion Therapeutics Inc's gross profit in fiscal 2020?
Flexion Therapeutics Inc reported gross profit of $66.3 million for fiscal 2020 (the year ended Dec 31, 2020), against $63 million the year before (+5.2%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What was Flexion Therapeutics Inc's operating income in fiscal 2020?
Flexion Therapeutics Inc reported operating income of -$93 million for fiscal 2020 (the year ended Dec 31, 2020), against -$136.3 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What was Flexion Therapeutics Inc's net income in fiscal 2020?
Flexion Therapeutics Inc reported net income of -$113.7 million for fiscal 2020 (the year ended Dec 31, 2020), against -$149.8 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What was Flexion Therapeutics Inc's cash from operating activities in fiscal 2020?
Flexion Therapeutics Inc reported cash from operating activities of -$70.6 million for fiscal 2020 (the year ended Dec 31, 2020), against -$148.8 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What was Flexion Therapeutics Inc's free cash flow in fiscal 2020?
Flexion Therapeutics Inc reported free cash flow of -$80.6 million for fiscal 2020 (the year ended Dec 31, 2020), against -$152.7 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What are Flexion Therapeutics Inc's total assets?
As of Dec 31, 2020, Flexion Therapeutics Inc reported total assets of $251.9 million, against $217.6 million a year earlier (+15.8%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What are Flexion Therapeutics Inc's total liabilities?
As of Dec 31, 2020, Flexion Therapeutics Inc reported total liabilities of $268.6 million, against $237.7 million a year earlier (+13%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What are Flexion Therapeutics Inc's cash and cash equivalents?
As of Dec 31, 2020, Flexion Therapeutics Inc reported cash and cash equivalents of $107.7 million, against $82.3 million a year earlier (+30.9%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC
What is Flexion Therapeutics Inc's total debt?
As of Dec 31, 2020, Flexion Therapeutics Inc reported total debt of $60.9 million, against $40.2 million a year earlier (+51.6%). Source: the 10-K filed with the SEC on Mar 10, 2021. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1419600&period_type=annual&limit=5"

Information only, not investment advice.